APA (7th ed.) Citation

Lim, E. H. T., Vlaar, A. P. J., de Bruin, S., Rückinger, S., Thielert, C., Habel, M., . . . Lobo, S. M. (2023). Pharmacokinetic analysis of vilobelimab, anaphylatoxin C5a and antidrug antibodies in PANAMO: A phase 3 study in critically ill,  invasively mechanically ventilated COVID-19 patients. Intensive Care Medicine Experimental, 11(1), 1. https://doi.org/10.1186/s40635-023-00520-8

Chicago Style (17th ed.) Citation

Lim, Endry H. T., et al. "Pharmacokinetic Analysis of Vilobelimab, Anaphylatoxin C5a and Antidrug Antibodies in PANAMO: A Phase 3 Study in Critically Ill,  invasively mechanically Ventilated COVID-19 Patients." Intensive Care Medicine Experimental 11, no. 1 (2023): 1. https://doi.org/10.1186/s40635-023-00520-8.

MLA (9th ed.) Citation

Lim, Endry H. T., et al. "Pharmacokinetic Analysis of Vilobelimab, Anaphylatoxin C5a and Antidrug Antibodies in PANAMO: A Phase 3 Study in Critically Ill,  invasively mechanically Ventilated COVID-19 Patients." Intensive Care Medicine Experimental, vol. 11, no. 1, 2023, p. 1, https://doi.org/10.1186/s40635-023-00520-8.